Avidity Biosciences, Inc. (RNAM) Balance sheet

Market cap

$11.3B

P/E ratio

	2020/12	2021/12	2022/12	2023/12	2024/12	2025/12
Cash and cash equivalents	321	320	341	185	223	385
Total cash & short-term investments	321	320	341	185	223	385
Total current assets	332	411	623	611	1,542	1,798
Property, plant and equipment, net	1	5	6	8	13	23
Total assets	334	428	639	629	1,564	1,958
Accounts payable	-	-	-	-	-	12
Total current liabilities	15	30	52	81	98	195
Total liabilities	28	46	61	128	139	269
Retained earnings	-67	-184	-358	-571	-893	-1,600
Stockholders' equity	306	381	578	501	1,425	1,689